This inventor holds 11 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Bioverativ Therapeutics Inc., Biogen Hemophila Inc.. Active years: 2016-2022.
Company Filing History:
Years Active: 2016-2022
Title: The Innovative Contributions of Samantha Truex
Introduction
Samantha Truex is a prominent inventor based in Sudbury, MA (US), known for her significant contributions to the field of biotechnology. With a total of 11 patents to her name, she has made remarkable advancements in the development of Factor IX polypeptides, which are crucial for treating hemophilia.
Latest Patents
Among her latest patents, Samantha has developed methods of using FIX polypeptides. This invention provides methods for administering long-acting Factor IX, as well as methods for producing chimeric and hybrid polypeptides that include Factor IX. Another notable patent focuses on Factor IX polypeptides and their methods of use, detailing the administration of chimeric and hybrid polypeptides, along with the polynucleotides encoding these polypeptides and the cells that comprise them.
Career Highlights
Samantha has worked with leading companies in the biotechnology sector, including Bioverativ Therapeutics Inc. and Biogen Hemophilia Inc. Her work in these organizations has been instrumental in advancing treatments for hemophilia and improving patient outcomes.
Collaborations
Throughout her career, Samantha has collaborated with esteemed colleagues such as Glenn Pierce and Robert T Peters. These partnerships have fostered innovation and have contributed to the success of her projects.
Conclusion
Samantha Truex's innovative work in the field of biotechnology, particularly in the development of Factor IX polypeptides, showcases her dedication to improving healthcare solutions. Her numerous patents and collaborations highlight her significant impact on the industry.